vs
FIRST UNITED CORP（FUNC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是FIRST UNITED CORP的1.5倍（$35.5M vs $23.2M），FIRST UNITED CORP净利率更高（24.9% vs -304.2%，领先329.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 11.9%），FIRST UNITED CORP自由现金流更多（$15.4M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 11.5%）
联合啤酒控股有限公司（又称UB集团）是喜力集团旗下的印度子公司，总部位于卡纳塔克邦班加罗尔的UB城。公司核心业务涵盖酒类饮品生产及多领域投资，是印度最大的啤酒生产商，主打以翠鸟为品牌的啤酒产品，同时拥有多款其他酒类品牌。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
FUNC vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.5倍
$23.2M
营收增速更快
RXRX
高出669.9%
11.9%
净利率更高
FUNC
高出329.1%
-304.2%
自由现金流更多
FUNC
多$62.7M
$-47.3M
两年增速更快
RXRX
近两年复合增速
11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $23.2M | $35.5M |
| 净利润 | $5.8M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 32.9% | -304.8% |
| 净利率 | 24.9% | -304.2% |
| 营收同比 | 11.9% | 681.7% |
| 净利润同比 | -6.6% | 39.6% |
| 每股收益（稀释后） | $0.89 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FUNCRXRX
| Q4 25 | $23.2M | $35.5M | ||
| Q3 25 | $22.7M | $5.2M | ||
| Q2 25 | $21.8M | $19.2M | ||
| Q1 25 | $20.9M | $14.7M | ||
| Q4 24 | $20.8M | $4.5M | ||
| Q3 24 | $20.3M | $26.1M | ||
| Q2 24 | $20.1M | $14.4M | ||
| Q1 24 | $18.7M | $13.8M |
净利润FUNCRXRX
| Q4 25 | $5.8M | $-108.1M | ||
| Q3 25 | $6.9M | $-162.3M | ||
| Q2 25 | $6.0M | $-171.9M | ||
| Q1 25 | $5.8M | $-202.5M | ||
| Q4 24 | $6.2M | $-178.9M | ||
| Q3 24 | $5.8M | $-95.8M | ||
| Q2 24 | $4.9M | $-97.5M | ||
| Q1 24 | $3.7M | $-91.4M |
毛利率FUNCRXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率FUNCRXRX
| Q4 25 | 32.9% | -304.8% | ||
| Q3 25 | 40.6% | -3327.6% | ||
| Q2 25 | 36.5% | -916.8% | ||
| Q1 25 | 36.8% | -1297.9% | ||
| Q4 24 | 39.2% | -4042.4% | ||
| Q3 24 | 38.0% | -377.1% | ||
| Q2 24 | 32.5% | -697.4% | ||
| Q1 24 | 26.0% | -698.4% |
净利率FUNCRXRX
| Q4 25 | 24.9% | -304.2% | ||
| Q3 25 | 30.6% | -3135.3% | ||
| Q2 25 | 27.5% | -894.2% | ||
| Q1 25 | 27.7% | -1373.3% | ||
| Q4 24 | 29.8% | -3935.5% | ||
| Q3 24 | 28.5% | -367.5% | ||
| Q2 24 | 24.5% | -676.6% | ||
| Q1 24 | 19.8% | -662.4% |
每股收益（稀释后）FUNCRXRX
| Q4 25 | $0.89 | $-0.17 | ||
| Q3 25 | $1.07 | $-0.36 | ||
| Q2 25 | $0.92 | $-0.41 | ||
| Q1 25 | $0.89 | $-0.50 | ||
| Q4 24 | $0.95 | $-0.56 | ||
| Q3 24 | $0.89 | $-0.34 | ||
| Q2 24 | $0.75 | $-0.40 | ||
| Q1 24 | $0.56 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $131.6M | $743.3M |
| 总债务越低越好 | $95.9M | $9.6M |
| 股东权益账面价值 | $203.6M | $1.1B |
| 总资产 | $2.1B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.47× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资FUNCRXRX
| Q4 25 | $131.6M | $743.3M | ||
| Q3 25 | $95.2M | $659.8M | ||
| Q2 25 | $79.1M | $525.1M | ||
| Q1 25 | $84.4M | $500.5M | ||
| Q4 24 | $78.3M | $594.4M | ||
| Q3 24 | $62.4M | $427.6M | ||
| Q2 24 | $45.1M | $474.3M | ||
| Q1 24 | $86.9M | $296.3M |
总债务FUNCRXRX
| Q4 25 | $95.9M | $9.6M | ||
| Q3 25 | $95.9M | $11.9M | ||
| Q2 25 | $120.9M | $14.2M | ||
| Q1 25 | $120.9M | $16.4M | ||
| Q4 24 | $120.9M | $19.0M | ||
| Q3 24 | $120.9M | $20.5M | ||
| Q2 24 | $70.9M | $22.9M | ||
| Q1 24 | $70.9M | — |
股东权益FUNCRXRX
| Q4 25 | $203.6M | $1.1B | ||
| Q3 25 | $199.1M | $1.0B | ||
| Q2 25 | $191.1M | $919.1M | ||
| Q1 25 | $183.7M | $933.9M | ||
| Q4 24 | $179.3M | $1.0B | ||
| Q3 24 | $174.0M | $524.6M | ||
| Q2 24 | $164.2M | $584.4M | ||
| Q1 24 | $165.5M | $401.2M |
总资产FUNCRXRX
| Q4 25 | $2.1B | $1.5B | ||
| Q3 25 | $2.0B | $1.4B | ||
| Q2 25 | $2.0B | $1.3B | ||
| Q1 25 | $2.0B | $1.3B | ||
| Q4 24 | $2.0B | $1.4B | ||
| Q3 24 | $1.9B | $726.5M | ||
| Q2 24 | $1.9B | $775.9M | ||
| Q1 24 | $1.9B | $557.8M |
负债/权益比FUNCRXRX
| Q4 25 | 0.47× | 0.01× | ||
| Q3 25 | 0.48× | 0.01× | ||
| Q2 25 | 0.63× | 0.02× | ||
| Q1 25 | 0.66× | 0.02× | ||
| Q4 24 | 0.67× | 0.02× | ||
| Q3 24 | 0.70× | 0.04× | ||
| Q2 24 | 0.43× | 0.04× | ||
| Q1 24 | 0.43× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $19.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $15.4M | $-47.3M |
| 自由现金流率自由现金流/营收 | 66.3% | -133.1% |
| 资本支出强度资本支出/营收 | 17.1% | 3.5% |
| 现金转化率经营现金流/净利润 | 3.35× | — |
| 过去12个月自由现金流最近4个季度 | $22.7M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流FUNCRXRX
| Q4 25 | $19.4M | $-46.1M | ||
| Q3 25 | $1.5M | $-117.4M | ||
| Q2 25 | $995.0K | $-76.4M | ||
| Q1 25 | $7.0M | $-132.0M | ||
| Q4 24 | $22.3M | $-115.4M | ||
| Q3 24 | $2.3M | $-59.2M | ||
| Q2 24 | $7.2M | $-82.2M | ||
| Q1 24 | $3.6M | $-102.3M |
自由现金流FUNCRXRX
| Q4 25 | $15.4M | $-47.3M | ||
| Q3 25 | $168.0K | $-117.6M | ||
| Q2 25 | $706.0K | $-79.6M | ||
| Q1 25 | $6.4M | $-133.8M | ||
| Q4 24 | $20.4M | $-116.7M | ||
| Q3 24 | $588.0K | $-63.8M | ||
| Q2 24 | $7.0M | $-83.4M | ||
| Q1 24 | $3.5M | $-109.0M |
自由现金流率FUNCRXRX
| Q4 25 | 66.3% | -133.1% | ||
| Q3 25 | 0.7% | -2272.5% | ||
| Q2 25 | 3.2% | -413.9% | ||
| Q1 25 | 30.5% | -907.4% | ||
| Q4 24 | 98.1% | -2567.7% | ||
| Q3 24 | 2.9% | -244.6% | ||
| Q2 24 | 35.1% | -578.5% | ||
| Q1 24 | 18.9% | -789.9% |
资本支出强度FUNCRXRX
| Q4 25 | 17.1% | 3.5% | ||
| Q3 25 | 5.9% | 4.7% | ||
| Q2 25 | 1.3% | 16.4% | ||
| Q1 25 | 2.8% | 12.4% | ||
| Q4 24 | 9.3% | 28.6% | ||
| Q3 24 | 8.4% | 17.5% | ||
| Q2 24 | 0.6% | 8.2% | ||
| Q1 24 | 0.3% | 48.2% |
现金转化率FUNCRXRX
| Q4 25 | 3.35× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.17× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 3.60× | — | ||
| Q3 24 | 0.40× | — | ||
| Q2 24 | 1.46× | — | ||
| Q1 24 | 0.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FUNC
| Trust Department | $9.8M | 42% |
| Other | $5.6M | 24% |
| Debit Card Income | $4.1M | 17% |
| Service Charges | $2.3M | 10% |
| Brokerage Commissions | $1.4M | 6% |
RXRX
暂无分部数据
